New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
07:48 EDTDHR, A, PKIPerkinElmer, Agilent unit seen as potential Danaher targets, Bloomberg says
With Danaher (DHR) having recently lost out to private equity firms on buyout targets it was seeking, analysts at Janney Montgomery Scott speculated that the conglomerate could set its sights on targets such as PerkinElmer (PKI), Agilent's (A) life sciences unit, or an international target like Oxford Instruments of the U.K., said Bloomberg's "Real M&A" column. Citigroup analysts suggest Danaher could also consider a breakup instead of an acquisition, the report noted. Reference Link
News For DHR;A;PKI From The Last 14 Days
Check below for free stories on DHR;A;PKI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
11:32 EDTPKILabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use